By Tim Ryan
In a remarkable recognition of its innovative prowess, ivWatch, a Hampton Roads-based medical technology firm, has been featured in PM360’s prestigious annual Innovations Issue. This honor, bestowed by one of the leading magazines in the life sciences and healthcare marketing sectors, underscores ivWatch’s significant contribution to advancing medical technology.
PM360 has highlighted ivWatch’s patented Patient Monitor and SmartTouch Sensor in the Health Technology, Non-Consumer category. This inclusion not only celebrates ivWatch’s cutting-edge technology but also aligns the company with some of the most groundbreaking advancements in life sciences, healthcare, and marketing.
ivWatch, recognized for its sole FDA-cleared and CE Marked continuous IV site monitoring technology, boasts a robust portfolio of 71 patents worldwide. These patents protect its core technologies and underscore the company’s relentless commitment to innovation. The medical device technology, notably the ivWatch Monitoring System and the SmartTouch Sensor, is designed to notify clinicians in real time of IV infiltrations or extravasations, detecting fluid leakage outside of the vein into surrounding tissue at the earliest stages. This capability is crucial in reducing patient harm and improving outcomes in IV therapy.
Erin Wendell, ivWatch’s Chief Marketing Officer, expressed pride in this recognition, emphasizing that ivWatch’s innovations are not merely products but solutions to a global healthcare challenge. By revolutionizing vascular access practices, ivWatch embraces science and provides clinicians with tools to make IV therapy safer.
PM360’s Innovations Issue, now in its 12th year, is a guide to the year’s most innovative advancements in various sectors. The 2023 issue expanded to include 13 categories, ranging from Artificial Intelligence to Telehealth/Telemedicine. Out of hundreds of submissions, only 56 innovations, including ivWatch’s, were selected by PM360’s editorial staff for this honor.
Anna Stashower, CEO, Publisher, and Editor-in-Chief of PM360, highlighted the importance of innovation across the life sciences, healthcare, and marketing industries. The selected innovations in the issue represent breakthroughs in various areas, from treatment development to patient care improvements.
ivWatch’s inclusion in this prestigious list is a testament to the company’s innovative spirit and its contribution to the medical field. It not only marks a significant milestone for the company but also shines a spotlight on Hampton Roads as a hub of technological innovation and healthcare advancement.
As we celebrate ivWatch’s achievement, we also recognize the broader impact of such innovation on our community and beyond. Hampton Roads continues to be a beacon of ingenuity and entrepreneurial spirit, leading the way in creating technologies that enhance patient care and improve medical outcomes. The recognition by PM360 is not just an honor for ivWatch but a celebration of the region’s ongoing commitment to pushing the boundaries of what’s possible in healthcare technology.
